All posts tagged
More News! Selexis’ acquisition & a potential cure for rare liver disease
Meet the New CEO of the Dutch Biotech Making a Cure for Blood Cancer
BRIEF: Dutch Biotech Goes for MAA in the EU with new Immunotherapy
EMA Paves the Way for a New Blood Cancer Immunotherapy for Children
Better and Safer Bone Marrow Transplants for Leukemia enter Phase III
Curing Cancer with Safer Transplants: UK Approval to start Clinical Trials
These are 10 of the Hottest Biotech Hubs in Europe
How is European Immuno-Oncology fighting Blood Cancer?
Stop and Smell the Tulips: 9 Amazing Biotechs in Amsterdam
It’s Blood Cancer Day, how is Biotech fixing it?
Dutch Leukemia Phase II Gets $1M Acceleration Funding from a Generous Charity
Biotech of the week: Kiadis Pharma, Immuno-therapy made in Amsterdam
Labiotech UG, All Rights Reserved -
Send this to friend